Industry Insights · Industry Bulletin Digest
Polymer Medical Device Bulletin 2025 Issue 3 digest: procurement changes and EU exports
Procurement rules and export pace were the device industry's top two concerns in 2025; this issue signals both.
Procurement: beyond lowest price
This issue records 'national procurement's eight changes, no longer anchored to lowest price', reflecting a shift from 'lowest price only' to broader quality and supply-stability considerations — with real impact on pricing and product strategy.
Exports: EU and the two Asias
- H1 2025 EU device exports topped USD 5B, with 10%+ growth to several countries;
- a status and outlook report for South and Southeast Asia;
- regional diversification as a hedge against single-market risk.
Regulation and quality
It releases the 2024 adverse-event annual report and regulatory statistics, and covers export sales certificate management, classification adjustments, online-sales quality on-site inspection and the registration self-test guide — helping firms grasp compliance.
The BIO angle
FAQ
What's the core of procurement's 'eight changes'?
The direction moves beyond anchoring to 'lowest price', weighing quality and supply stability more — a rule-optimization signal.
How big were H1 2025 EU exports?
Over USD 5B, with 10%+ growth to several countries; the EU is a key growth market.
What are 'the two Asias'?
South Asia and Southeast Asia — emerging regional markets where China's device exports grow fast.
Related reading
- Polymer Medical Device Bulletin 2025 Issue 1 Digest: Regulatory Reform and Annual Data | BIO Insights
- Polymer Medical Device Bulletin 2025 Issue 4 Digest: Device Law and Materials Challenge | BIO Insights
- Polymer Medical Device Bulletin 2026 Issue 1 Digest: Annual Highlights and UDI Progress | BIO Insights
Note: an original analysis compiled from public industry information; figures and conclusions per official/original sources. Not investment advice.
Building in China's medical-device market?
From advanced medical silicone/polymers to material selection, regulatory and supply, BIO helps global and local partners move from selection to landed supply in China.